DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results May 5, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--May 5, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2021. DiaMedica will host a conference call Thursday, May 6, 2021, at 7:00 a.m. Cen...